Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Accordi

Radiopharmaceuticals in Nuclear Medicine Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

 

Radiopharmaceuticals in Nuclear Medicine Market
Radiopharmaceuticals in Nuclear Medicine Market 

The report's market dynamics section elaborates on the current market drivers, restraints, challenges/risks, and upcoming opportunities. This section is likely to be of great interest to any company's strategists and new product development team. The study segments the global Radiopharmaceuticals in Nuclear Medicine market and provides market size in terms of revenue and/or sales. This information is divided into regions and then countries. The information is gathered through in-depth primary interviews with industry experts all over the world. Our sample reports contain detailed methodology. These market estimates are also influenced by the most recent social, political, and economic changes, as well as current market dynamics affecting the Radiopharmaceuticals in Nuclear Medicine market.

The market's key players are focusing on obtaining approvals, which is expected to drive Radiopharmaceuticals in Nuclear Medicine market growth over the forecast period. NorthStar Medical Radioisotopes, LLC, for example, received FDA approval in February 2018 for its RadioGenix System, an innovative, high-tech radioisotope separation platform indicated for use in producing widely-used medical radioisotope technetium-99 (Tc-99m) from NorthStar's non-uranium-based molybdenum-99 (Mo-99).

Following the COVID-19 outbreak in December 2019, the disease has spread to over 100 countries around the world, prompting the World Health Organization to declare it a public health emergency. According to the World Health Organization, the coronavirus (COVID-19) manifestation has resulted in more than 27.8 million infected individuals worldwide as of September 2020.

Comments

Popular posts from this blog

Global Disposable Face Mask Market Share

Future Prospects of Global Laboratory Proficiency Testing Market

Global Ophthalmoscopes Market Overview and Impact of Coronavirus (Covid-19) Pandemic